imipramine has been researched along with Phobic Disorders in 115 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 9.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "At the end of a two-week single-blind placebo baseline, 43 patients with a diagnosis of panic disorder with agoraphobia without significant dysphoria-depression and with moderate to severe panic and phobic symptoms were assigned to, and 32 of them completed, a placebo-controlled (n = 7) dose-response study with three weight-adjusted imipramine hydrochloride dosages: 0." | 9.06 | Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. ( Mavissakalian, MR; Perel, JM, 1989) |
| "A double-blind clinical trial of zimeldine, a potent inhibitor of central serotonin reuptake, versus imipramine and placebo was carried out on 44 patients suffering from agoraphobia with panic attacks." | 9.06 | Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. ( Evans, L; Hoey, H; Kenardy, J; Schneider, P, 1986) |
| "Thirty-seven patients participating in a controlled treatment study with imipramine were classified as high or low depressed simultaneously on two depression measures." | 9.06 | Initial depression and response to imipramine in agoraphobia. ( Mavissakalian, M, 1987) |
| "This naturalistic study examined the treatment response to imipramine of 60 patients who had panic disorder or agoraphobia with panic attacks." | 9.06 | A naturalistic study of imipramine in panic disorder and agoraphobia. ( Aronson, TA, 1987) |
| " We studied the binding of tritiated imipramine to platelet membranes in order to determine if patients with agoraphobia and panic attacks differed from depressed subjects or healthy volunteers on this biological parameter." | 7.67 | Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. ( Clancy, J; Coryell, W; Lewis, DA; Noyes, R, 1985) |
| "The authors examined dose-response relationships in 62 agoraphobic patients receiving either imipramine or placebo under double-blind conditions in conjunction with behavioral interventions." | 6.66 | Imipramine in the treatment of agoraphobia: dose-response relationships. ( Mavissakalian, M; Perel, J, 1985) |
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 5.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "At the end of a two-week single-blind placebo baseline, 43 patients with a diagnosis of panic disorder with agoraphobia without significant dysphoria-depression and with moderate to severe panic and phobic symptoms were assigned to, and 32 of them completed, a placebo-controlled (n = 7) dose-response study with three weight-adjusted imipramine hydrochloride dosages: 0." | 5.06 | Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. ( Mavissakalian, MR; Perel, JM, 1989) |
| "A double-blind clinical trial of zimeldine, a potent inhibitor of central serotonin reuptake, versus imipramine and placebo was carried out on 44 patients suffering from agoraphobia with panic attacks." | 5.06 | Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. ( Evans, L; Hoey, H; Kenardy, J; Schneider, P, 1986) |
| "Thirty-seven patients participating in a controlled treatment study with imipramine were classified as high or low depressed simultaneously on two depression measures." | 5.06 | Initial depression and response to imipramine in agoraphobia. ( Mavissakalian, M, 1987) |
| "This naturalistic study examined the treatment response to imipramine of 60 patients who had panic disorder or agoraphobia with panic attacks." | 5.06 | A naturalistic study of imipramine in panic disorder and agoraphobia. ( Aronson, TA, 1987) |
| "Six subjects with the phobic-anxiety syndrome were treated in a controlled, crossover trial of clonidine hydrochloride v imipramine hydrochloride for periods of four weeks each." | 5.05 | Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine. ( Elsworth, JD; Ko, GN; Leigh, H; Redmond, DE; Rifkin, BG; Roth, RH, 1983) |
| "The psychopharmacological treatment of separation anxiety is reviewed, with special emphasis on the use of tricyclic antidepressants." | 3.75 | Relationship between separation anxiety and panic and agoraphobic disorders. ( Gittelman, R; Klein, DF, 1984) |
| " We studied the binding of tritiated imipramine to platelet membranes in order to determine if patients with agoraphobia and panic attacks differed from depressed subjects or healthy volunteers on this biological parameter." | 3.67 | Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. ( Clancy, J; Coryell, W; Lewis, DA; Noyes, R, 1985) |
| "3H-Imipramine (3H-IMI) binding to platelet membranes was measured in 19 patients with agoraphobia with panic attacks, 9 patients with major depression, and 22 healthy subjects." | 3.67 | Differential 3H-imipramine platelet binding in patients with panic disorder and depression. ( Charney, DS; Heninger, GR; Innis, RB, 1987) |
| "This study was designed to see whether the high vs low serum level of imipramine influenced the outcome of in vivo exposure therapy on patients with agoraphobia." | 3.67 | Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. ( Ballenger, JC; Cox, DJ; Hobbs, WR; Hucek, A; Laraia, M; Peterson, GA, 1988) |
| "Reports that imipramine and phenelzine prevent panic attacks in agoraphobia suggest the possibility that agoraphobia and/or panic disorder might be a clinical manifestation of underlying depression." | 3.66 | The dexamethasone suppression test in panic disorder and agoraphobia. ( Cameron, OG; Curtis, GC; Nesse, RM, 1982) |
| "Although the FDA recommends imipramine hydrochloride (IMI) only for temporary relief of symptoms of enuresis nocturna (EN), the drug has been applied to a number of other pediatric situations, including the Hyperkinetic Syndrome (HS), childhood depression, somnambulism and pavor nocturnus, school phobia, petit mal epilepsy, allergies, autism, encorpresis and head-banging." | 3.65 | Imipramine and children: a review and some speculations about the mechanism of drug action. ( Gualtieri, CT, 1977) |
| "Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients." | 2.67 | Is buspirone effective for panic disorder? ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1990) |
| "Imipramine was superior to placebo in lowering panic and avoidance at both postbaseline time points." | 2.66 | Panic and avoidance in agoraphobia. Application of path analysis to treatment studies. ( Cohen, P; Klein, DF; Ross, DC, 1987) |
| "The authors examined dose-response relationships in 62 agoraphobic patients receiving either imipramine or placebo under double-blind conditions in conjunction with behavioral interventions." | 2.66 | Imipramine in the treatment of agoraphobia: dose-response relationships. ( Mavissakalian, M; Perel, J, 1985) |
| "Brief therapist-aided exposure improved phobias and panics to a significant but limited extent, and is a useful adjuvant to self-exposure homework, which can be a powerful therapeutic agency by itself." | 2.65 | Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework. ( Cohen, D; Gray, S; Hill, R; Marks, IM; Mawson, D; Ramm, E; Stern, RS, 1983) |
| "In a controlled-outcome study of phobias, 218 adult phobic patients (147 women and 71 men) received a course of 26 weekly treatment sessions that consisted of behavior therapy (BT) and imipramine hydrochloride, BT and placebo, or supportive psychotherapy and imipramine." | 2.65 | Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. ( Klein, DF; Ross, DC; Woerner, MG; Zitrin, CM, 1983) |
| "Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior." | 2.65 | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. ( Ballenger, J; Jacobsen, G; Sheehan, DV, 1980) |
| "In a controlled outcome study of phobias, 111 adult patients (69% women, 31% men) received a course of 26 weekly treatment sessions consisting of (1) behavior therapy and imipramine hydrochloride (2) behavior therapy and placebo, or (3) supportive psychotherapy and imipramine." | 2.64 | Behavior therapy, supportive psychotherapy, imipramine, and phobias. ( Klein, DF; Woerner, MG; Zitrin, CM, 1978) |
| "A review of the literature on treatments for agoraphobia highlights the conclusion reached, that the agoraphobic patient presents with a biopsychosocial problem which frequently requires the clinician to combine several treatment modalities." | 1.27 | Agoraphobia: a multimodal treatment approach. ( Schwartz, LS; Val, ER, 1984) |
| "A case is reported of a boy with Tourette's syndrome whose panic attacks were successfully treated with imipramine." | 1.27 | Imipramine treatment of panic disorder in a boy with Tourette's syndrome. ( Sverd, J, 1988) |
| "The hallmark of agoraphobia is the spontaneous panic attack, a reaction of extreme fearfulness and impending doom with cardiorespiratory symptoms." | 1.26 | Current drug therapy for agoraphobia. ( Ravaris, CL, 1981) |
| "Sulpiride was administered to 21 children with school phobia." | 1.25 | Sulpiride in school phobia. ( Abe, K, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 101 (87.83) | 18.7374 |
| 1990's | 10 (8.70) | 18.2507 |
| 2000's | 3 (2.61) | 29.6817 |
| 2010's | 1 (0.87) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, KD | 1 |
| TELLENBACH, H | 2 |
| Noyes, R | 4 |
| Carney, CP | 1 |
| Langbehn, DR | 1 |
| Zitrin, CM | 8 |
| Klein, DF | 23 |
| Woerner, MG | 5 |
| Ross, DC | 4 |
| Marks, IM | 3 |
| Gray, S | 1 |
| Cohen, D | 1 |
| Hill, R | 1 |
| Mawson, D | 1 |
| Ramm, E | 1 |
| Stern, RS | 1 |
| Telch, MJ | 3 |
| Tearnan, BH | 1 |
| Taylor, CB | 4 |
| Cobb, J | 1 |
| Zelnik, TC | 1 |
| Garcia-Sevilla, JA | 1 |
| Cameron, OG | 2 |
| Smith, CB | 1 |
| Cohen, SD | 1 |
| Monteiro, W | 1 |
| Pohl, R | 3 |
| Rainey, JM | 2 |
| Gershon, S | 2 |
| Gittelman, R | 1 |
| Van Winter, JT | 1 |
| Stickler, GB | 1 |
| Michelson, L | 8 |
| Mavissakalian, M | 14 |
| Meminger, S | 1 |
| Dealy, RS | 1 |
| Last, CG | 2 |
| Barlow, DH | 1 |
| O'Brien, GT | 1 |
| Petit, M | 1 |
| Perel, JM | 2 |
| Schwartz, LS | 1 |
| Val, ER | 1 |
| Perel, J | 2 |
| Frances, A | 1 |
| Petti, TA | 1 |
| Matuzas, W | 2 |
| Glass, RM | 1 |
| Ko, GN | 1 |
| Elsworth, JD | 1 |
| Roth, RH | 1 |
| Rifkin, BG | 1 |
| Leigh, H | 1 |
| Redmond, DE | 1 |
| Fier, M | 1 |
| Davis, JM | 1 |
| Nasr, S | 1 |
| Spira, N | 1 |
| Vogel, C | 1 |
| Sheehan, DV | 4 |
| Curtis, GC | 1 |
| Nesse, RM | 1 |
| Kaplan, HS | 1 |
| Fyer, AJ | 5 |
| Novick, A | 1 |
| Shrand, H | 1 |
| Berchou, R | 1 |
| Rock, MH | 1 |
| Goldberger, L | 1 |
| Ballenger, J | 1 |
| Jacobsen, G | 1 |
| Ravaris, CL | 1 |
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Alpert, JE | 1 |
| Maddocks, A | 1 |
| Rosenbaum, JF | 2 |
| Fava, M | 1 |
| Pollack, MH | 1 |
| Otto, MW | 1 |
| Sachs, GS | 1 |
| Leon, A | 1 |
| Shear, MK | 1 |
| Deltito, JA | 1 |
| Keller, MB | 1 |
| Simpson, HB | 1 |
| Schneier, FR | 1 |
| Campeas, RB | 1 |
| Marshall, RD | 1 |
| Fallon, BA | 1 |
| Davies, S | 1 |
| Liebowitz, MR | 4 |
| Lipsitz, JD | 1 |
| Mannuzza, S | 1 |
| Bernstein, GA | 3 |
| Borchardt, CM | 2 |
| Perwien, AR | 1 |
| Crosby, RD | 1 |
| Kushner, MG | 1 |
| Thuras, PD | 1 |
| Anderson, LK | 1 |
| Hektner, JM | 1 |
| Realmuto, GM | 1 |
| Lindemann, C | 1 |
| Tobak, P | 1 |
| Rock, M | 1 |
| Kaplan, JE | 1 |
| Ganz, VH | 1 |
| Gualtieri, CT | 1 |
| Saraf, KR | 1 |
| Gittelman-Klein, R | 2 |
| Gootman, N | 1 |
| Greenhill, P | 1 |
| Abe, K | 1 |
| Argyle, N | 1 |
| Solyom, C | 1 |
| Solyom, L | 1 |
| Sargent, M | 1 |
| Garfinkel, BD | 1 |
| Jackson, CW | 1 |
| Lydiard, RB | 2 |
| Raj, AB | 1 |
| Sheehan, KH | 1 |
| Soto, S | 1 |
| Mavissakalian, MR | 1 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Garvey, MJ | 1 |
| Cook, BL | 1 |
| Samuelson, L | 1 |
| Ballenger, JC | 2 |
| Carek, DJ | 1 |
| Steele, JJ | 1 |
| Cornish-McTighe, D | 1 |
| Brady, K | 1 |
| Zarzar, M | 1 |
| King, R | 1 |
| Margraf, J | 1 |
| Ehlers, A | 1 |
| Telch, M | 1 |
| Roth, WT | 3 |
| Agras, WS | 3 |
| Gallen, CC | 1 |
| Freedman, AM | 1 |
| Scrignar, CB | 1 |
| Rizley, R | 1 |
| Kahn, RJ | 1 |
| McNair, DM | 1 |
| Frankenthaler, LM | 1 |
| Cohen, P | 1 |
| Pecknold, JC | 1 |
| Scott, WB | 1 |
| Fleming, BM | 1 |
| Kritkausky, RP | 1 |
| Lelliott, P | 1 |
| Marks, I | 2 |
| Evans, L | 1 |
| Kenardy, J | 1 |
| Schneider, P | 1 |
| Hoey, H | 1 |
| Lewis, DA | 1 |
| Coryell, W | 1 |
| Clancy, J | 1 |
| Innis, RB | 1 |
| Charney, DS | 1 |
| Heninger, GR | 1 |
| O'Sullivan, G | 1 |
| Cox, DJ | 1 |
| Laraia, M | 1 |
| Hobbs, WR | 1 |
| Peterson, GA | 1 |
| Hucek, A | 1 |
| Aronson, TA | 1 |
| Lelliott, PT | 1 |
| Monteiro, WO | 1 |
| Tsakiris, F | 1 |
| Noshirvani, H | 1 |
| Gorman, JM | 3 |
| Sverd, J | 1 |
| Dillon, D | 1 |
| Cohen, BS | 1 |
| Ananth, J | 1 |
| Surman, OS | 1 |
| Williams, J | 1 |
| Strom, TB | 1 |
| Jones, KJ | 1 |
| Coleman, J | 1 |
| Robinson, ML | 1 |
| Jones, A | 1 |
| Crowe, RR | 1 |
| Ambrosini, P | 1 |
| Uhde, TW | 1 |
| Berrettini, WH | 1 |
| Roy-Byrne, PP | 1 |
| Boulenger, JP | 1 |
| Post, RM | 1 |
| Schneider, LS | 1 |
| Munjack, D | 1 |
| Severson, JA | 1 |
| Palmer, R | 1 |
| Davies, SO | 1 |
| Benca, R | 1 |
| Al-Sadir, J | 1 |
| Jenike, MA | 1 |
| Pato, C | 1 |
| Stewart, JT | 1 |
| Lawlor, BA | 1 |
| Honigfeld, G | 1 |
| Feldman, S | 1 |
| Quitkin, MQ | 1 |
| Rifkin, A | 2 |
| Lader, MH | 1 |
| Quitkin, FM | 1 |
| Kaplan, J | 1 |
| Snaith, RP | 1 |
| Rabiner, CJ | 1 |
| Mendel, JG | 1 |
14 reviews available for imipramine and Phobic Disorders
| Article | Year |
|---|---|
Specific phobia of illness: search for a new subtype.
Topics: Antidepressive Agents, Tricyclic; Attitude to Health; Humans; Imipramine; Phobic Disorders; Psychoth | 2004 |
Antidepressant medication in the treatment of agoraphobia: a critical review.
Topics: Agoraphobia; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine | 1983 |
Behaviour therapy in phobic and obsessional disorders.
Topics: Agoraphobia; Arousal; Behavior Therapy; Clomipramine; Cognition; Combined Modality Therapy; Desensit | 1983 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
Relationship between separation anxiety and panic and agoraphobic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Anxiety, Separation; Child; Clinical Trials as Topic; Fear; F | 1984 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
Topics: Agoraphobia; Behavior Therapy; Fear; Humans; Imipramine; Mental Disorders; Panic; Phobic Disorders | 1989 |
Psychopharmacology and psychotherapy in the treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1986 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Behavior Therapy; Humans; Imipramine; Phobic Disorders | 1988 |
Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review.
Topics: Agoraphobia; Antidepressive Agents; Fear; Habituation, Psychophysiologic; Humans; Imipramine; Obsess | 1988 |
A model of panic and agoraphobic development.
Topics: Agoraphobia; Anxiety Disorders; Autonomic Nervous System; Fear; Humans; Imipramine; Panic; Phobic Di | 1987 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Physiological measures in psychiatry.
Topics: Adaptation, Psychological; Amobarbital; Animals; Anxiety; Arousal; Blood Pressure; Depression; Elect | 1971 |
51 trials available for imipramine and Phobic Disorders
| Article | Year |
|---|---|
Treatment of agoraphobia with group exposure in vivo and imipramine.
Topics: Adult; Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Female; Group Processes; Humans; | 1980 |
Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients?
Topics: Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Humans; Imipramine; Person-Centered Psy | 1983 |
Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
Topics: Adult; Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Female; Follow-Up Studies; Human | 1983 |
Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
Topics: Adult; Agoraphobia; Ambulatory Care; Behavior Therapy; Clinical Trials as Topic; Female; Humans; Imi | 1983 |
Two-year follow-up of agoraphobics after exposure and imipramine.
Topics: Adult; Agoraphobia; Behavior Therapy; Female; Follow-Up Studies; Humans; Imipramine; Male; Phobic Di | 1984 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
Relationship between separation anxiety and panic and agoraphobic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Anxiety, Separation; Child; Clinical Trials as Topic; Fear; F | 1984 |
Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
Topics: Adult; Agoraphobia; Anxiety; Behavior Therapy; Combined Modality Therapy; Female; Humans; Imipramine | 1983 |
The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
Topics: Adult; Agoraphobia; Desipramine; Female; Humans; Imipramine; Male; Phobic Disorders | 1984 |
Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine.
Topics: Adult; Anxiety Disorders; Clonidine; Double-Blind Method; Fear; Female; Glycols; Humans; Imipramine; | 1983 |
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
Level of ego development and psychotherapy outcome in phobic patients.
Topics: Adult; Behavior Therapy; Ego; Female; Humans; Imipramine; Male; Middle Aged; Outcome and Process Ass | 1981 |
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
Topics: Adult; Anxiety; Depression; Double-Blind Method; Female; Humans; Hypochondriasis; Hysteria; Imiprami | 1980 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; | 1994 |
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imip | 1994 |
Imipramine in the treatment of social phobia.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Imipramine; Male; Middle Aged; Phobic Disor | 1998 |
Specific phobia 10-16 years after treatment.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Behavior Therapy; Chi-Square Distribution; Co | 1999 |
Imipramine plus cognitive-behavioral therapy in the treatment of school refusal.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cognitive Behavioral Therapy; Combined Modality | 2000 |
Imipramine compliance in adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cognitive Behavioral Therapy; Combined Modality | 2000 |
Comparison of short-term treatment regimens in phobic patients: a preliminary report.
Topics: Adult; Agoraphobia; Ambulatory Care; Behavior Therapy; Clinical Trials as Topic; Desensitization, Ps | 1976 |
Behavior therapy, supportive psychotherapy, imipramine, and phobias.
Topics: Adult; Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Female; Follow-Up Studies; Human | 1978 |
Imipramine and phobia [proceedings].
Topics: Agoraphobia; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Imipramine; Male; Phobic Dis | 1977 |
Imipramine, behavior therapy, and phobia.
Topics: Agoraphobia; Behavior Therapy; Clinical Trials as Topic; Female; Humans; Imipramine; Male; Phobic Di | 1975 |
The structure of phobias in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; | 1991 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Is buspirone effective for panic disorder?
Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Buspirone; Double-Blind Method; Fear; Female; Follow | 1990 |
Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
Topics: Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Rel | 1989 |
Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
Topics: Adult; Agoraphobia; Brain; Buspirone; Clinical Trials as Topic; Double-Blind Method; Fear; Female; H | 1989 |
Combined pharmacological and behavioral treatment for agoraphobia.
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Desensitization, Psychologic; Human | 1985 |
Psychopharmacology and psychotherapy in the treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1986 |
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as To | 1986 |
Clinically significant improvement in agoraphobia research.
Topics: Adolescent; Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Desensitization, Psycho | 1986 |
The placebo effect in agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Desensitization, Psychologic; Femal | 1987 |
Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
Topics: Adult; Agoraphobia; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Combined Modality | 1987 |
Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Double-Blind Method; Fear; Female; Humans; Imipramine; | 1986 |
The relationship between panic, phobic and anticipatory anxiety in agoraphobia.
Topics: Adolescent; Adult; Agoraphobia; Clinical Trials as Topic; Fear; Female; Humans; Imipramine; Male; Mi | 1988 |
Initial depression and response to imipramine in agoraphobia.
Topics: Agoraphobia; Clinical Trials as Topic; Depression; Depressive Disorder; Dose-Response Relationship, | 1987 |
A naturalistic study of imipramine in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear; | 1987 |
Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.
Topics: Adult; Agoraphobia; Behavior Therapy; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; I | 1987 |
Autonomic changes after treatment of agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Arousal; Behavior Therapy; Combined Modality Therapy; Fear; Humans; Imipramine; | 1988 |
Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
Topics: Adult; Agoraphobia; Anxiety Disorders; Behavior Therapy; Chronic Disease; Clinical Trials as Topic; | 1986 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Two-year follow-up of exposure and imipramine treatment of agoraphobia.
Topics: Agoraphobia; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Depressive Disor | 1986 |
Lactate vulnerability of remitted panic patients.
Topics: Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; D | 1985 |
Imipramine in the treatment of agoraphobia: dose-response relationships.
Topics: Agoraphobia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug A | 1985 |
Psychophysiological outcome of behavioral and pharmacological treatments of agoraphobia.
Topics: Adolescent; Adult; Aged; Agoraphobia; Behavior Therapy; Female; Heart Rate; Humans; Imipramine; Impl | 1985 |
Prediction of drug effect by diagnostic decision tree.
Topics: Anxiety; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Factor Analysis, St | 1968 |
Psychiatric diagnosis and a typology of clinical drug effects.
Topics: Affective Symptoms; Analysis of Variance; Anger; Bipolar Disorder; Chlorpromazine; Clinical Trials a | 1968 |
Treatment of phobias.
Topics: Clinical Trials as Topic; Humans; Imipramine; Monoamine Oxidase Inhibitors; Phobic Disorders | 1971 |
55 other studies available for imipramine and Phobic Disorders
| Article | Year |
|---|---|
Anxiety in youth.
Topics: Adolescent; Anxiety Disorders; Child; Comorbidity; Cross-Sectional Studies; Humans; Imipramine; Impl | 2010 |
[ON THE TREATMENT OF PHOBIC AND ANANCASTIC STATES WITH IMIPRAMINE].
Topics: Humans; Imipramine; Neurotic Disorders; Obsessive-Compulsive Disorder; Phobic Disorders | 1963 |
Differential treatment of phobias: use of imipramine for panic attacks.
Topics: Adult; Agoraphobia; Desensitization, Psychologic; Fear; Female; Humans; Imipramine; Male; Panic; Pho | 1983 |
Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Blood Platelets; Clonidine; Drug Therapy, Combination; Fear; Humans; Imipramine; | 1982 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
Prognostic utility of Locus of Control in treatment of agoraphobia.
Topics: Adolescent; Adult; Aged; Agoraphobia; Female; Humans; Imipramine; Implosive Therapy; Internal-Extern | 1983 |
Panic attacks in phobia treatment studies.
Topics: Agoraphobia; Fear; Humans; Imipramine; Panic; Phobic Disorders | 1983 |
Imipramine with or without cognitive-behavior therapy in the treatment of an agoraphobic.
Topics: Agoraphobia; Behavior Therapy; Cognition; Combined Modality Therapy; Humans; Imipramine; Male; Middl | 1983 |
[Semeiology of anxiety].
Topics: Adult; Aged; Anxiety; Anxiety, Separation; Child, Preschool; Humans; Imipramine; Infant; Infant, New | 1983 |
Agoraphobia: a multimodal treatment approach.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Female; Humans; Imipramine; Marital Therapy; Panic; P | 1984 |
The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
Topics: Agoraphobia; Desipramine; Humans; Imipramine; Phobic Disorders | 1984 |
Boy with seriously ill mother manifests somatic complaints, withdrawal, disabling fears.
Topics: Adjustment Disorders; Child; Child Reactive Disorders; Combined Modality Therapy; Desipramine; Famil | 1984 |
Treatment of agoraphobia and panic attacks.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Double-Blind Method; Fear; Humans; Imipramine; Pan | 1983 |
Agoraphobia: the 'what if' syndrome.
Topics: Adolescent; Adult; Agoraphobia; Female; Humans; Imipramine; Male; Phenelzine; Phobic Disorders; Psyc | 1981 |
The dexamethasone suppression test in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Dexamethasone; Diagnosis, Differential; | 1982 |
The treatment of sexual phobias: the combined use of antipanic medication and sex therapy.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Female; Humans; Imipramine; Male; Monoamine Oxidas | 1982 |
Patterns of psychophysiological change in the treatment of agoraphobia.
Topics: Adult; Agoraphobia; Arousal; Female; Humans; Imipramine; Implosive Therapy; Phobic Disorders | 1982 |
Agoraphobia and imipramine withdrawal?
Topics: Agoraphobia; Female; Humans; Imipramine; Infant, Newborn; Infant, Newborn, Diseases; Phobic Disorder | 1982 |
Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Clomipramine; Diazepam; Double-Blind Method; Humans; | 1982 |
Current drug therapy for agoraphobia.
Topics: Adult; Agoraphobia; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Imipramine; Ph | 1981 |
Imipramine and children: a review and some speculations about the mechanism of drug action.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Depression; Dopamine; Enuresis; Epilepsy, Absence; | 1977 |
Case 1. Assessment and treatment of phobic anxiety.
Topics: Adjustment Disorders; Adult; Agoraphobia; Anxiety; Behavior Therapy; Diagnosis, Differential; Female | 1979 |
EKG effects of imipramine treatment in children.
Topics: Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart; Humans; Imipramine; Mal | 1978 |
Sulpiride in school phobia.
Topics: Adolescent; Child; Drug Evaluation; Female; Humans; Imipramine; Male; Phobic Disorders; Remission, S | 1975 |
Panic disorder.
Topics: Alprazolam; Behavior Therapy; Fear; Health Education; Humans; Imipramine; National Health Programs; | 1990 |
Two cases of activation/jitteriness associated with TCAs.
Topics: Adult; Akathisia, Drug-Induced; Arousal; Humans; Imipramine; Male; Middle Aged; Phobic Disorders | 1990 |
Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ap | 1989 |
Three cases of panic disorder with agoraphobia in children.
Topics: Adolescent; Agoraphobia; Alprazolam; Child; Fear; Female; Humans; Imipramine; Male; Panic; Phobic Di | 1989 |
Fluoxetine in panic disorder patients with imipramine-associated weight gain.
Topics: Adult; Agoraphobia; Depressive Disorder; Fear; Female; Fluoxetine; Humans; Imipramine; Middle Aged; | 1989 |
Use of medication and in vivo exposure in volunteers for panic disorder research.
Topics: Adult; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; | 1989 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
Behavioural and combined therapy in panic states.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Cognition; Combined Modality Therapy; Desensitizat | 1987 |
Drug therapy for agoraphobia.
Topics: Agoraphobia; Desensitization, Psychologic; Evaluation Studies as Topic; Humans; Imipramine; Phobic D | 1988 |
The cause and treatment of agoraphobia.
Topics: Agoraphobia; Anxiety Disorders; Arousal; Desensitization, Psychologic; Humans; Imipramine; Life Chan | 1988 |
Tritiated imipramine binding to platelets is decreased in patients with agoraphobia.
Topics: Adolescent; Adult; Aged; Agoraphobia; Bipolar Disorder; Blood Platelets; Carrier Proteins; Depressiv | 1985 |
Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
Topics: Agoraphobia; Blood Platelets; Carrier Proteins; Depressive Disorder; Fear; Humans; Imipramine; Kinet | 1987 |
Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia.
Topics: Adolescent; Adult; Aged; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Dose-Response Rel | 1988 |
Imipramine treatment of panic disorder in a boy with Tourette's syndrome.
Topics: Age Factors; Anxiety Disorders; Child, Preschool; Fear; Humans; Imipramine; Male; Panic; Phobic Diso | 1988 |
Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
Topics: Adult; Agoraphobia; Alprazolam; Clonidine; Desipramine; Fear; Female; Fluoxetine; Humans; Imipramine | 1987 |
Imipramine treatment of agoraphobia.
Topics: Agoraphobia; Double-Blind Method; Humans; Imipramine; Phobic Disorders; Research Design | 1987 |
Anxiety reconceptualized. Gleaning from pharmacological dissection--early experience with imipramine and anxiety.
Topics: Agoraphobia; Anxiety Disorders; Anxiety, Separation; Arousal; Behavior Therapy; Combined Modality Th | 1987 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Anxiety, Separation; Behavior Therapy; Combined Modality Therapy; Humans; I | 1987 |
Panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Animals; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Diagnosis, Differ | 1986 |
Imipramine binding in agoraphobia.
Topics: Agoraphobia; Depressive Disorder; Humans; Imipramine; Phobic Disorders | 1986 |
Platelet [3H]imipramine binding in patients with panic disorder.
Topics: Adult; Blood Platelets; Fear; Female; Humans; Imipramine; Kinetics; Male; Middle Aged; Mood Disorder | 1987 |
Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Platelets; Female; Humans; Imipramine; Kinetics; Male; | 1987 |
Social phobia, MVP, and response to imipramine.
Topics: Adult; Female; Humans; Imipramine; Interpersonal Relations; Male; Mitral Valve Prolapse; Panic; Phob | 1986 |
Disabling fear of AIDS responsive to imipramine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Fear; Humans; Imipramine; Male; Phobic Disorders | 1986 |
Depression, agoraphobia, and the DST.
Topics: Agoraphobia; Depressive Disorder; Dexamethasone; Female; Humans; Imipramine; Middle Aged; Phobic Dis | 1985 |
School phobia: diagnostic considerations in the light of imipramine effects.
Topics: Adolescent; Anxiety, Separation; Behavior Therapy; Child; Child Behavior; Evaluation Studies as Topi | 1973 |
Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.
Topics: Adult; Anxiety; Electroconvulsive Therapy; Ethanol; Evaluation Studies as Topic; Female; Hospitaliza | 1972 |
A study of imipramine in the treatment of phobias.
Topics: Humans; Imipramine; Phobic Disorders; Psychiatric Status Rating Scales | 1972 |
Imipramine treatment of school phobia.
Topics: Adolescent; Anxiety, Separation; Child; Child Behavior Disorders; Humans; Imipramine; Phobic Disorde | 1969 |
Anxiety attacks with subsequent agoraphobia.
Topics: Adolescent; Adult; Anxiety; Behavior Therapy; Female; Humans; Imipramine; Male; Phobic Disorders; Se | 1969 |
[Directed treatment of phobia of being hurt (blaptophobia) with imipramine].
Topics: Bipolar Disorder; Electroconvulsive Therapy; Humans; Imipramine; Phobic Disorders; Quinidine | 1966 |